The article advocates for equitable access to biologic treatments for patients with severe asthma, emphasizing the need to update Ordinance No. 261/2024/1 to ensure that these patients receive the same level of care as those with other chronic conditions. It frames this issue as an ethical and social imperative, highlighting the injustice faced by asthma patients in accessing necessary medical treatments.